Florac is a family office focused on a variety of investments and acquisitions across the US and Western Europe (France, Belgium, Italy and Switzerland). Florac looks to commit $20 to $150 million per transaction to support a variety of transaction situations, including growth capital financings, recapitalizations, and buyouts. Florac does not have sector preferences and generally pursues indefinite investment time horizons. Florac was established in 2009 and is headquartered in Paris, France.
Join Mergr to view the latest updates and news from Florac.
In the last 3 years, Florac has acquired 1 company. It has also invested in 2 others.
Florac’s most common sectors for investment are real estate (25%) and beverages (13%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (50%) and growth capital (25%). In total, Florac has invested in 2 US states and 5 different countries. Its largest (disclosed) acquisition occurred in 2015 when it acquired SANI S.A. for -.
In the last 3 years, Florac has exited 3 companies. The Firm’s most common exit type is secondary buyout (67%). Florac’s largest (disclosed) exit occurred in 2016 when it sold TCR Group for $225M.
Join Mergr to view Florac’s full profile and discover more small private equity firms just like it.
No obligation. Cancel anytime.